Phase I/II trial of PYN17 in patients with chronic hepatitis C

Trial Profile

Phase I/II trial of PYN17 in patients with chronic hepatitis C

Completed
Phase of Trial: Phase I/II

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs PYN 17 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Sponsors Phynova
  • Most Recent Events

    • 16 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top